Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2008-07-04 M&A Activity
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
M&A Activity 2008
M&A Activity Classification · 99% confidence The document is a press release dated July 4, 2008, announcing that Vitrolife has acquired an additional 9% stake in A.T.S. Srl, increasing its ownership to 60%. This transaction involves the acquisition of shares and changes in ownership structure, which falls under corporate actions related to capital or financing activities, or potentially major shareholding changes. However, the core event is the acquisition of a subsidiary/distributor, which is a form of corporate transaction that impacts capital structure and strategy. Reviewing the definitions, 'Capital/Financing Update (CAP)' covers fundraising, financing activities, or capital structure changes. While this is an acquisition, it is a significant transaction impacting ownership. 'Major Shareholding Notification (MRQ)' is for changes in significant ownership levels crossing thresholds, which this is, but it's an active acquisition by the reporting company, not just a notification of passive ownership change. Given the context of acquiring a stake in another company, which is a form of corporate transaction often grouped with financing/capital structure changes, 'CAP' is a strong candidate. However, the most direct fit for an announcement about acquiring shares in another entity, especially when it involves increasing ownership stake, is often categorized under M&A Activity (TAR) or Capital Change (SHA). Since this is an acquisition of a minority stake (increasing control), and not a full takeover (TAR), and it's not about issuing new shares by the reporting company (SHA), the closest fit among the provided options that covers significant corporate transactions impacting ownership structure is 'CAP' (Capital/Financing Update) or potentially 'RNS' (General Regulatory Filings) if it's treated as a standard corporate announcement. Given the nature of increasing ownership in a key market distributor, it is a strategic capital move. If we strictly follow the definitions, 'TAR' (M&A Activity) is for merger proposals or takeover bids, which this isn't explicitly. 'CAP' covers capital structure changes. Since this is a press release announcing a specific corporate transaction (share acquisition), and it doesn't fit perfectly into the other specific categories like ER, IR, or DIRS, it is a general corporate announcement. In many databases, specific acquisitions are often classified under M&A (TAR) or general corporate news (RNS). Since it's an acquisition of a stake, and not a full merger, and it's not a standard financial report, I will classify it as a general regulatory announcement, which is the fallback for specific corporate news not covered elsewhere, or potentially M&A if the acquisition is deemed significant enough. Given the options, and that it's a strategic acquisition announcement, 'TAR' (M&A Activity) is often used broadly for significant transactions, but 'RNS' (Regulatory Filings) is the safest fallback for non-standard corporate news. Let's re-evaluate: It is a press release announcing a strategic acquisition of shares. This is a significant corporate event. If 'TAR' is strictly for M&A proposals/takeovers, and 'CAP' is for fundraising/financing, this transaction (acquiring a stake) is closest to a transaction impacting capital structure or M&A. I will lean towards 'RNS' as the most appropriate general category for a press release detailing a specific, non-standard corporate transaction that doesn't fit the financial reporting codes (10-K, IR, ER) or specific insider/dividend codes. However, upon reviewing similar filings, strategic acquisitions often fall under M&A (TAR) even if they are partial acquisitions. Given the options, and the nature of the transaction (acquiring control in a distributor), I will select TAR as the best fit for a significant corporate transaction, although RNS is a possibility. Let's check the definitions again. TAR is 'Merger proposals or takeover bids'. This is an acquisition of a stake. I will revert to RNS as the most accurate general category for a press release announcing a specific corporate action that isn't a standard financial report or a defined event like a dividend or director dealing.
2008-07-04 Swedish
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is explicitly labeled as a "Press release" dated June 18, 2008, announcing that the "STEEN Solution™ [is] approved for sales in Australia." This is a specific, time-sensitive announcement regarding regulatory/market access approval for a product. It is not a comprehensive annual report (10-K), an interim report (IR), a transcript (CT), or a formal shareholder communication like a proxy statement (PSI) or AGM material (AGM-R). Since it is a specific announcement that doesn't fit the detailed financial report categories (ER, AR, IR) or insider trading/governance categories (DIRS, MANG), it falls best under the general category for miscellaneous regulatory/corporate announcements, which is Regulatory Filings (RNS). It is too specific to be a general 'Report Publication Announcement' (RPA) as it is announcing an event/approval, not the publication of a separate, attached report.
2008-06-18 English
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a press release dated June 18, 2008, announcing that Vitrolife's product, STEEN Solution™, has been approved for sale in Australia. This type of announcement, which communicates a specific, material event (regulatory approval/product news) outside of the standard periodic financial reports (like 10-K or IR), typically falls under general regulatory announcements or news releases. Since there is no specific category for 'Product Approval Announcement' and it is not a transcript (CT), a formal financial report (10-K, IR), or a management/board change (MANG), the most appropriate general category is Regulatory Filings (RNS), which serves as a catch-all for significant, non-standard corporate news releases that are often filed with regulators. The document length (4121 chars) is substantial enough that it is the primary content, not just a brief notice of publication (RPA).
2008-06-18 Swedish
AGM Information 2008
AGM Information Classification · 99% confidence The document is explicitly titled "Kommuniké från årsstämma" (Communication from the Annual General Meeting) and details the resolutions passed at the meeting held on April 29th, including decisions on dividends, board re-elections, and authorization for new share issues/option grants. This content directly relates to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length is short (3303 chars) and it is a summary/communication, not a full regulatory filing like a 10-K or IR.
2008-04-30 Swedish
AGM Information 2008
AGM Information Classification · 99% confidence The document is explicitly titled "Report from Annual General Meeting" and details decisions made at the meeting held on April 29, 2008, including dividend decisions, board re-elections, authorizations for share issuance, and approval of remuneration principles. These contents directly align with the definition of AGM Information, which corresponds to the filing code AGM-R. The document is a report of the outcomes, not just an announcement of a future meeting or a proxy solicitation.
2008-04-30 English
Interim / Quarterly Report 2008
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–March 2008 for Vitrolife AB. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance, market segments, and future outlook. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2008
2008-04-28 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.